Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis genetics.
Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Multiple sclerosis and family planning.
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
Anodal tDCS increases corticospinal output and projection strength in multiple sclerosis.
[Applications of Optical Coherence Tomography (OCT) in Neuro-ophthalmology.]
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.
NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Single-cell imaging of bioenergetic responses to neuronal excitotoxicity and oxygen and glucose deprivation.
[Autonomic neuropathies].
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.
Pages
« first
‹ previous
…
346
347
348
349
350
351
352
353
354
…
next ›
last »